New heart catheter shows promise for AFib patients
NCT ID NCT05971693
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 25 times
Summary
This study tested the safety and effectiveness of a new catheter system (OMNYPULSE with TRUPULSE generator) for treating paroxysmal atrial fibrillation, a type of irregular heartbeat. 188 participants underwent a procedure to isolate the pulmonary veins using this system. The main goals were to check for serious side effects within 7 days and to see if the procedure successfully stopped abnormal electrical signals from the veins.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AZ Sint-Jan
Bruges, 8000, Belgium
-
AZORG campus Aalst Moorselbaan
Aalst, 9300, Belgium
-
Generale Regionale F. Miulli
Acquaviva delle Fonti, 70021, Italy
-
IKEM
Prague, 140 21, Czechia
-
Jessa Ziekenhuis - Campus Virga Jesse
Hasselt, 3500, Belgium
-
KBC Split
Split, 21000, Croatia
-
MVZ CCB Frankfurt und Main Taunus GbR
Frankfurt a.M., 60431, Germany
-
Maastricht UMC
Maastricht, 6229 HX, Netherlands
-
McGill University Health Centre
Montreal, Quebec, H3G 1A4, Canada
-
Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
-
Nemocnice na Homolce
Prague, 150 30 District 5, Czechia
-
Vilnius University Hospital Santariskiu Klinikos
Vilnius, 08661, Lithuania
-
Ziekenhuis Oost-Limburg
Genk, 3600, Belgium
Conditions
Explore the condition pages connected to this study.